top of page


SYFOVRE (APLS) vs. IZERVAY (Astellas)
Tough month for APLS • 1st: safety issue surfaces for SYFOVRE ⇨ Retinal Vasculitis • Now: IZERVAY approved early ⇨ Good for AMD patients...
Aug 7, 2023


Apellis Pharmaceuticals (APLS)
BIOPHARMA STOCK NEWS FLASH APLS provides SYFOVRE safety update Background: SYFOVRE approved by FDA • Feb 2023 • pegcetacoplan injection •...
Jul 31, 2023
Amarin Corporation (AMRN)
Nearing 5 yrs since Reduce- It results
Jul 30, 2023
Apellis Pharmaceuticals (APLS)
BIOPHARMA STOCK NEWS FLASH
Jul 30, 2023


How to make $$$ investing in biopharma
Consistent with top 36 biopharma hedge funds • Each held 22-125 companies @ end Q1 ⇒ Stonepine (22 companies) ⇒ EcoR1 (58) ⇒ RA Capital...
Jul 24, 2023
How to make $$$ investing in biopharma
Consistent with top 36 biopharma hedge funds
Jul 23, 2023


Finally... Therapeutics that slow Alzheimer’s
But, which is the best? • Some anti-beta amyloids (ABs) made it ⇒ thru pos Ph3 ⇒ 1 full FDA approval But lots of ABs have died in...
Jul 14, 2023
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page
